About RhineGene

RhineGene is an innovative biotechnology company aiming to be a supporter of healthcare professionals in providing high-quality care for the detection and diagnosis of various diseases and achieving the best outcomes for patients.

Founded in 2022 in the Netherlands, the company brings high-quality molecular diagnostic products to professionals worldwide and continues its sales activities on the international stage with its subsidiaries in the Philippines, Bulgaria, Poland, and Germany.

RhineGene offers a wide range of products with a portfolio including Real-Time PCR kits, nucleic acid extraction kits, Real-Time PCR instruments, and automated nucleic acid extraction robots. The company’s mission is to stand by patients, improve their lives, protect public health, and support healthcare professionals throughout these processes.

High-Quality Healthcare

Unique product portfolio, including more than 350 Real-Time PCR kits, covers a wide range of applications for detection, quantitation, and genotyping of pathogens, identification, and screening of genetic disorders as well as food safety parameters.

RhineGene provides turnkey solutions with instruments including automated nucleic acid extraction robots and Real-Time PCR detection systems with absolute dedication to performance and quality.